|
1
|
Pakzad R, Mohammadian-Hafshejani A,
Khosravi B, Soltani S, Pakzad I, Mohammadian M, Salehiniya H and
Momenimovahed Z: The incidence and mortality of esophageal cancer
and their relationship to development in Asia. Ann Transl Med.
4:292016.PubMed/NCBI
|
|
2
|
Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y,
Ueda J, Wei W, Inoue M and Tanaka H: Epidemiology of esophageal
cancer in Japan and China. J Epidemiol. 23:233–242. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tepper JE: Is radiation therapy needed in
the treatment of gastroesophageal junction adenocarcinoma?
Gastrointest Cancer Res. 2(4 Suppl): S2–S5. 2008.PubMed/NCBI
|
|
5
|
Linkous AG and Yazlovitskaya EM: Novel
radiosensitizing anticancer therapeutics. Anticancer Res.
32:2487–2499. 2012.PubMed/NCBI
|
|
6
|
Kotake Y, Nakagawa T, Kitagawa K, Suzuki
S, Liu N, Kitagawa M and Xiong Y: Long non-coding RNA ANRIL is
required for the PRC2 recruitment to and silencing of p15(INK4B)
tumor suppressor gene. Oncogene. 30:1956–1962. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu HA and Bernstein E: Partners in
imprinting: Noncoding RNA and polycomb group proteins. Dev Cell.
15:637–638. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Morales D Rivea, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes and affect gene
expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chu C, Qu K, Zhong FL, Artandi SE and
Chang HY: Genomic maps of long noncoding RNA occupancy reveal
principles of RNA-chromatin interactions. Mol Cell. 44:667–678.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kogo R, Shimamura T, Mimori K, Kawahara K,
Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al:
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin
modification and is associated with poor prognosis in colorectal
cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bhan A and Mandal SS: LncRNA HOTAIR: A
master regulator of chromatin dynamics and cancer. Biochim Biophys
Acta. 1856:151–164. 2015.PubMed/NCBI
|
|
13
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang Z, Zhou L, Wu LM, Lai MC, Xie HY,
Zhang F and Zheng SS: Overexpression of long non-coding RNA HOTAIR
predicts tumor recurrence in hepatocellular carcinoma patients
following liver transplantation. Ann Surg Oncol. 18:1243–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kogo R, Shimamura T, Mimori K, Kawahara K,
Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al:
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin
modification and is associated with poor prognosis in colorectal
cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu ZH, Wang XL, Tang HM, Jiang T, Chen J,
Lu S, Qiu GQ, Peng ZH and Yan DW: Long non-coding RNA HOTAIR is a
powerful predictor of metastasis and poor prognosis and is
associated with epithelial-mesenchymal transition in colon cancer.
Oncol Rep. 32:395–402. 2014.PubMed/NCBI
|
|
17
|
Niinuma T, Suzuki H, Nojima M, Nosho K,
Yamamoto H, Takamaru H, Yamamoto E, Maruyama R, Nobuoka T, Miyazaki
Y, et al: Upregulation of miR-196a and HOTAIR drive malignant
character in gastrointestinal stromal tumors. Cancer Res.
72:1126–1136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu XH, Liu ZL, Sun M, Liu J, Wang ZX and
De W: The long non-coding RNA HOTAIR indicates a poor prognosis and
promotes metastasis in non-small cell lung cancer. BMC Cancer.
13:4642013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim K, Jutooru I, Chadalapaka G, Johnson
G, Frank J, Burghardt R, Kim S and Safe S: HOTAIR is a negative
prognostic factor and exhibits pro-oncogenic activity in pancreatic
cancer. Oncogene. 32:1616–1625. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nie Y, Liu X, Qu S, Song E, Zou H and Gong
CL: Non-coding RNA HOTAIR is an independent prognostic marker for
nasopharyngeal carcinoma progression and survival. Cancer Sci.
104:458–464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li D, Feng J, Wu T, Wang Y, Sun Y, Ren J
and Liu M: Long intergenic noncoding RNA HOTAIR is overexpressed
and regulates PTEN methylation in laryngeal squamous cell
carcinoma. Am J Pathol. 182:64–70. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cui L, Xie XY, Wang H, Chen XL, Liu SL and
Hu LN: Expression of long non-coding RNA HOTAIR mRNA in ovarian
cancer. Sichuan Da Xue Xue Bao Yi Xue Ban. 44:57–59. 2013.(In
Chinese). PubMed/NCBI
|
|
23
|
Sung CO, Park CK and Kim SH:
Classification of epithelial-mesenchymal transition phenotypes in
esophageal squamous cell carcinoma is strongly associated with
patient prognosis. Mod Pathol. 24:1060–1068. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iwatsuki M, Mimori K, Yokobori T, Ishi H,
Beppu T, Nakamori S, Baba H and Mori M: Epithelialmesenchymal
transition in cancer development and its clinical significance.
Cancer Sci. 101:293–299. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen LQ: Understanding and appraisal of
the new TNM classification for esophageal cancer in the AJCC Cancer
Staging Manual (7th edition). Zhonghua Zhong Liu Za Zhi.
32:237–240. 2010.PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sharma S, Kelly TK and Jones PA:
Epigenetics in cancer. Carcinogemesis. 31:27–36. 2010. View Article : Google Scholar
|
|
29
|
Banerjee HN and Verma M: Epigenetic
mechanisms in cancer. Biomark Med. 3:397–410. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li SQ, Wang HM and Cao XF: Potential
clinical insights into microRNAs and their target genes in
esophageal carcinoma. Biomarkers. 16:629–636. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin R, Maeda S, Liu C, Karin M and
Edgington TS: A large noncoding RNA is a marker for murine
hepatocellular carcinomas and a spectrum of human carcinomas.
Oncogene. 26:851–858. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Matouk IJ, DeGroot N, Mezan S, Ayesh S,
Abu-lail R, Hochberg A and Galun E: The H19 non-coding RNA is
essential for human tumor growth. PLoS One. 2:e8452007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pasmant E, Sabbagh A, Masliah-Planchon J,
Ortonne N, Laurendeau I, Melin L, Ferkal S, Hernandez L, Leroy K,
Valeyrie-Allanore L, et al: Role of noncoding RNA ANRIL in genesis
of plexiform neurofibromas in neurofibromatosis type 1. J Natl
Cancer Inst. 103:1713–1722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Silva JM, Boczek NJ, Berres MW, Ma X and
Smith DI: LSINCT5 is overexpressed in breast and ovarian cancer and
affects cellular proliferation. RNA Biol. 8:496–505. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Srikantan V, Zou Z, Petrovics G, Xu L,
Augustus M, Davis L, Livezey JR, Connell T, Sesterhenn IA, Yoshino
K, et al: PCGEM1, a prostate-specific gene, is overexpressed in
prostate cancer. Proc Natl Acad Sci USA. 97:12216–12221. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kurrey NK, Jalgaonkar SP, Joglekar AV,
Ghanate AD, Chaskar PD, Doiphode RY and Bapat SA: Snail and slug
mediate radioresistance and chemoresistance by antagonizing
p53-mediated apoptosis and acquiring a stem-like phenotype in
ovarian cancer cells. Stem Cells. 27:2059–2068. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The role of snail in EMT and tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Galván JA, González MV, Crespo G,
Folgueras MV and Astudillo A: Snail nuclear expression parallels
higher malignancy potential in neuroendocrine lung tumors. Lung
Cancer. 69:289–295. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Olmeda D, Moreno-Bueno G, Flores JM, Fabra
A, Portillo F and Cano A: SNAI1 is required for tumor growth and
lymph node metastasis of human breast carcinoma MDA-MB-231 cells.
Cancer Res. 67:11721–11731. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Francí C, Gallén M, Alameda F, Baró T,
Iglesias M, Virtanen I and García de Herreros A: Snail1 protein in
the stroma as a new putative prognosis marker for colon tumours.
PLoS One. 4:e55952009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nishioka R, Itoh S, Gui T, Gai Z, Oikawa
K, Kawai M, Tani M, Yamaue H and Muragaki Y: SNAIL induces
epithelial-to-mesenchymal transition in a human pancreatic cancer
cell line (BxPC3) and promotes distant metastasis and invasiveness
in vivo. Exp Mol Pathol. 89:149–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jin H, Yu Y, Zhang T, Zhou X, Zhou J, Jia
L, Wu Y, Zhou BP and Feng Y: Snail is critical for tumor growth and
metastasis of ovarian carcinoma. Int J Cancer. 126:2102–2111.
2010.PubMed/NCBI
|
|
44
|
Aamodt R, Bondi J, Andersen SN, Bakka A,
Bukholm G and Bukholm IR: The prognostic impact of protein
expression of E-cadherin-catenin complexes differs between rectal
and colon carcinoma. Gastroenterol Res Pract. 2010:6160232010.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kang H, Min BS, Lee KY, Kim NK, Kim SN,
Choi J and Kim H: Loss of E-cadherin and MUC2 expressions
correlated with poor survival in patients with stages II and III
colorectal carcinoma. Ann Surg Oncol. 18:711–719. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chelidonis G, Kavantzas N, Patsouris E,
Pagaki E, Agrogiannis G and Athanasiadou P: DNA ploidy, E-cadherin,
beta-catenin expression and their clinicopathologic significance in
imprints of non-small cell lung cancer. Anal Quant Cytol Histol.
31:332–339. 2009.PubMed/NCBI
|
|
47
|
Baumgart E, Cohen MS, Neto B Silva, Jacobs
MA, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M,
Libertino JA and Summerhayes IC: Identification and prognostic
significance of an epithelial-mesenchymal transition expression
profile in human bladder tumors. Clin Cancer Res. 13:1685–1694.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Christofori G and Semb H: The role of the
cell-adhesion molecule E-cadherin as a tumour suppressor gene.
Trends Biochem Sci. 24:73–76. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Adhikary A, Chakraborty S, Mazumdar M,
Ghosh S, Mukherjee S, Manna A, Mohanty S, Nakka KK, Joshi S, De A,
et al: Inhibition of epithelial to mesenchymal transition by
E-cadherin up-regulation via repression of slug transcription and
inhibition of E-cadherin degradation: Dual role of scaffold/matrix
attachment region-binding protein 1 (SMAR1) in breast cancer cells.
J Biol Chem. 289:25431–25444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Beck TN, Chikwem AJ, Solanki NR and
Golemis EA: Bioinformatic approaches to augment study of
epithelial-to-mesenchymal transition (EMT) in lung cancer. Physiol
Genomics. 2014:699–724. 2014. View Article : Google Scholar
|
|
51
|
Zheng H, Li W, Wang Y, Xie T, Cai Y, Wang
Z and Jiang B: miR-23a inhibits E-cadherin expression and is
regulated by AP-1 and NFAT4 complex during Fas-induced EMT in
gastrointestinal cancer. Carcinogenesis. 35:173–183. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhao Z, Ge J, Sun Y, Tian L, Lu J, Liu M
and Zhao Y: Is E-cadherin immunoexpression a prognostic factor for
head and neck squamous cell carcinoma (HNSCC)? A systematic review
and meta-analysis. Oral Oncol. 48:761–767. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ge XS, Ma HJ, Zheng XH, Ruan HL, Liao XY,
Xue WQ, Chen YB, Zhang Y and Jia WH: HOTAIR, A prognostic factor in
esophageal squamous cell carcinoma, inhibits WIF-1 expression and
activates Wnt pathway. Cancer Sci. 104:1675–1682. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xu ZY, Yu QM, Du YA, Yang LT, Dong RZ,
Huang L, Yu PF and Cheng XD: Knockdown of long non-coding RNA
HOTAIR suppresses tumor invasion and reverses epithelial-
mesenchymal transition in gastric cancer. Int J Biol Sci.
9:587–597. 2013. View Article : Google Scholar : PubMed/NCBI
|
